Over 20 years experience in biotech, leading teams. Team leader at Gendaq, CSO/CEO at Isogenica. Consultant in molecular evolution, peptide, antibody discovery and delivery technologies.
18 years of experience researching oncolytic viruses and has held roles of increasing seniority in academia. Ex-Head of Molecular Virology at PsiOxus, a leading oncolytic virus company.
Head of BD and Strategic Alliances in Therapeutics at Deep Science Ventures, ex Associate Director of Cancer Research UK’s Commercial Partnerships team. Extensive experience in oncology deal-making, including transacting licences, collaboration and spin-outs.